It is not Aduhelm redux. Accordingly, there’s been moderately rising demand for the drug since its July 2023 approval. Nonetheless, the therapeutic hasn’t nearly gathered the kind of momentum ...
Please confirm that you would like to log out of Medscape. If you log out, you will be required to enter your username and password the next time you visit. Log out ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results